NCT01027910 - PCI-24781 in Combination With Doxorubicin to Treat Sarcoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Sarcoma

Interventions

DRUG

PCI-24781

Capsules taken orally for 5 consecutive days starting on Day 1 of each 3 week cycle

DRUG

Doxorubicin

Administered intravenously on Day 4 of each 3 week cycle

DRUG

GCSF

Administered on Day 5 of each 3 weeks cycle in Arm 1 if determined to be clinically indicated, and in all patients enrolled into Arm 2

Trial Locations (2)

Massachusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston